Publisher： Karger
E-ISSN： 1421-9913|64|4|236-240
ISSN： 0014-3022
Source： European Neurology, Vol.64, Iss.4, 2010-09, pp. : 236-240
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
European Neurology, Vol. 67, Iss. 3, 2012-01 ,pp. :
Access to resources
Recommend
Observational Study of Switching from Natalizumab to Immunomodulatory Drugs
European Neurology, Vol. 77, Iss. 3-4, 2017-01 ,pp. :
Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
Medical Principles and Practice, Vol. 22, Iss. 5, 2013-06 ,pp. :
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients
European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. :
Natalizumab and Regulation of Cerebral Blood Flow: Results from an Observational Study
European Neurology, Vol. 64, Iss. 2, 2010-07 ,pp. :